Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial
Authors
Keywords
-
Journal
CEPHALALGIA
Volume -, Issue -, Pages 033310242210820
Publisher
SAGE Publications
Online
2022-03-09
DOI
10.1177/03331024221082077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update
- (2021) Christina Sun-Edelstein et al. CNS DRUGS
- Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
- (2021) Marcello Silvestro et al. Frontiers in Neurology
- Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
- (2021) Andrew M. Blumenfeld et al. Pain and Therapy
- Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability
- (2020) Domenico D'Amico et al. International Journal of Environmental Research and Public Health
- Greater occipital nerve block in migraine prophylaxis: Narrative review
- (2019) Levent Ertugrul Inan et al. CEPHALALGIA
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis
- (2019) Lin Han et al. Brain and Behavior
- Current and emerging evidence-based treatment options in chronic migraine: a narrative review
- (2019) Elio Clemente Agostoni et al. JOURNAL OF HEADACHE AND PAIN
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
- (2018) Lars Bendtsen et al. JOURNAL OF HEADACHE AND PAIN
- Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
- (2016) K.-L. Lai et al. ACTA NEUROLOGICA SCANDINAVICA
- Greater occipital nerve block in the treatment of triptan-overuse headache: A randomized comparative study
- (2016) Ö. Karadaş et al. ACTA NEUROLOGICA SCANDINAVICA
- Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial
- (2016) María L Cuadrado et al. CEPHALALGIA
- Topiramate in Migraine Prevention: A 2016 Perspective
- (2016) Stephen D. Silberstein HEADACHE
- Chronic migraine: risk factors, mechanisms and treatment
- (2016) Arne May et al. Nature Reviews Neurology
- Systematic Review of Migraine Prophylaxis Adherence and Persistence
- (2016) Zsolt Hepp et al. JOURNAL OF MANAGED CARE PHARMACY
- Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study
- (2015) L. E. Inan et al. ACTA NEUROLOGICA SCANDINAVICA
- Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches - A Narrative Review
- (2013) Andrew Blumenfeld et al. HEADACHE
- Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine
- (2012) S. D. Silberstein et al. NEUROLOGY
- Acupuncture versus topiramate in chronic migraine prophylaxis: A randomized clinical trial
- (2011) C-P Yang et al. CEPHALALGIA
- Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial
- (2011) Elizabeth Leroux et al. LANCET NEUROLOGY
- A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine
- (2010) Renan B. Domingues et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Cushing Syndrome Induced by Serial Occipital Nerve Blocks Containing Corticosteroids
- (2010) Patrick J. Lavin et al. HEADACHE
- Suboccipital Nerve Blocks for Suppression of Chronic Migraine: Safety, Efficacy, and Predictors of Outcome
- (2010) Silvia Weibelt et al. HEADACHE
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
- Occipital Nerve Blocks: Effect of Symptomatic Medication
- (2009) Joshua A. Tobin et al. HEADACHE
- Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study
- (2007) A Ashkenazi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started